Harvard Apparatus Regenerative Technology Files 2024 DEF 14A
Ticker: HRGN · Form: DEF 14A · Filed: Apr 29, 2025 · CIK: 1563665
| Field | Detail |
|---|---|
| Company | Harvard Apparatus Regenerative Technology, Inc. (HRGN) |
| Form Type | DEF 14A |
| Filed Date | Apr 29, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: def-14a, executive-compensation, corporate-governance
Related Tickers: HRGN
TL;DR
HRGN filed its 2024 DEF 14A, detailing exec pay & governance. Shareholders vote soon.
AI Summary
Harvard Apparatus Regenerative Technology, Inc. (HRGN) filed a DEF 14A on April 29, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other corporate governance matters. The company was formerly known as Biostage, Inc. until March 31, 2016.
Why It Matters
This filing provides crucial information for shareholders regarding executive compensation, director elections, and other significant corporate decisions that can impact the company's future performance and stock value.
Risk Assessment
Risk Level: medium — DEF 14A filings often contain information about executive compensation and corporate governance that can signal potential risks or opportunities for investors.
Key Numbers
- 2024 — Fiscal Year End (The filing covers the company's performance and governance for this year.)
- 20250429 — Filing Date (This is the date the DEF 14A was officially submitted to the SEC.)
Key Players & Entities
- Harvard Apparatus Regenerative Technology, Inc. (company) — Filer
- Biostage, Inc. (company) — Former company name
- 0001563665 (company) — Central Index Key
- 20250429 (date) — Filing date
- 20250620 (date) — Period of report
- 2024-12-31 (date) — Fiscal year end
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose of this DEF 14A filing is to provide shareholders with information regarding the company's annual meeting, including details on executive compensation, director nominations, and other corporate governance matters.
When is the period of report for this filing?
The period of report for this filing is 20250620, indicating the relevant timeframe for the information presented.
What was Harvard Apparatus Regenerative Technology, Inc. formerly known as?
Harvard Apparatus Regenerative Technology, Inc. was formerly known as Biostage, Inc. until March 31, 2016.
What is the company's fiscal year end?
The company's fiscal year end is December 31 (1231).
What is the company's SIC code?
The company's Standard Industrial Classification (SIC) code is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 29, 2025 regarding Harvard Apparatus Regenerative Technology, Inc. (HRGN).